Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Maschmeyer

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Der Internist|January 20, 2016
[Specific infections in organ transplantation]M Cornberg, B Schlevogt, J Rademacher, et al.
Annals of Hematology|February 16, 2013
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)S Neumann, S W Krause, G Maschmeyer, et al.
Annals of Hematology|November 1, 1994
Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for ChemotherapyH Link, G Maschmeyer, P Meyer, et al.
Annals of Hematology|April 16, 1998
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patientsG Behre, H Link, G Maschmeyer, et al.
Annals of Hematology|July 1, 1997
Management of infections during intensive treatment of hematologic malignanciesG Maschmeyer, W Hiddemann, H Link, et al.
Cancer Treatment Reviews|September 1, 1990
High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia--preliminary clinical and pharmacological data of a randomized comparisonW Hiddemann, E Schleyer, C Uhrmeister, et al.
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1994
[Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society]G Maschmeyer, H Link, W Hiddemann, et al.
Cancer|May 1, 1994
Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter studyG Maschmeyer, H Link, W Hiddemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2009
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patientsG Maschmeyer, S Neuburger, L Fritz, et al.
Leukemia & Lymphoma|September 1, 1994
Combined immunophenotyping and karyotyping in peripheral T cell lymphomas demonstrating different clonal and nonclonal chromosome aberrations in T helper cellsB Schlegelberger, K Weber-Matthiesen, W Sterry, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Der Internist|January 20, 2016
[Specific infections in organ transplantation]M Cornberg, B Schlevogt, J Rademacher, et al.
Annals of Hematology|February 16, 2013
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)S Neumann, S W Krause, G Maschmeyer, et al.
Annals of Hematology|November 1, 1994
Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for ChemotherapyH Link, G Maschmeyer, P Meyer, et al.
Annals of Hematology|April 16, 1998
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patientsG Behre, H Link, G Maschmeyer, et al.
Annals of Hematology|July 1, 1997
Management of infections during intensive treatment of hematologic malignanciesG Maschmeyer, W Hiddemann, H Link, et al.
Cancer Treatment Reviews|September 1, 1990
High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia--preliminary clinical and pharmacological data of a randomized comparisonW Hiddemann, E Schleyer, C Uhrmeister, et al.
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1994
[Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society]G Maschmeyer, H Link, W Hiddemann, et al.
Cancer|May 1, 1994
Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter studyG Maschmeyer, H Link, W Hiddemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2009
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patientsG Maschmeyer, S Neuburger, L Fritz, et al.
Leukemia & Lymphoma|September 1, 1994
Combined immunophenotyping and karyotyping in peripheral T cell lymphomas demonstrating different clonal and nonclonal chromosome aberrations in T helper cellsB Schlegelberger, K Weber-Matthiesen, W Sterry, et al.
Pageof 9